PRECISION BIOSCIENCES INC — Director's Dealing 2022

Mar 23, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2022-03-21

Reporting Person: Amoroso Michael (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-03-21	Employee Stock Option (Right to Buy)	$3.05	A	482771	Acquired	2032-03-20	Common Stock (482771)	Direct
2022-03-21	Restricted Stock Units	$	A	307544	Acquired		Common Stock (307544)	Direct

Footnotes

F1: The option vests as to 25% of the underlying shares on March 21, 2023 and thereafter in twelve substantially equal installments at the end of each three-month period over the 36 months following such date, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

F2: The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of the Company's Common Stock.

F3: The RSUs shall vest in three substantially equal annual installments beginning on March 21, 2023, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.